184 related articles for article (PubMed ID: 38169746)
41. Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer.
Chen J; Zhu T; Jiang G; Zeng Q; Li Z; Huang X
Mol Cancer; 2023 Aug; 22(1):131. PubMed ID: 37563723
[TBL] [Abstract][Full Text] [Related]
42. Chimeric antigen receptor-engineered T-cell therapy for liver cancer.
Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325
[TBL] [Abstract][Full Text] [Related]
43. Deletion of Cbl-b inhibits CD8
Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
[TBL] [Abstract][Full Text] [Related]
44. Construction of chimeric antigen receptor‑modified T cells targeting EpCAM and assessment of their anti‑tumor effect on cancer cells.
Zhou Y; Wen P; Li M; Li Y; Li XA
Mol Med Rep; 2019 Sep; 20(3):2355-2364. PubMed ID: 31322180
[TBL] [Abstract][Full Text] [Related]
45. Circulating CEA-positive and EpCAM-negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer.
Miki Y; Yashiro M; Kuroda K; Okuno T; Togano S; Masuda G; Kasashima H; Ohira M
Cancer Med; 2021 Jan; 10(2):521-528. PubMed ID: 33381922
[TBL] [Abstract][Full Text] [Related]
46. Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models.
Yang Y; Yang H; Alcaina Y; Puc J; Birt A; Vedvyas Y; Gallagher M; Alla S; Riascos MC; McCloskey JE; Du K; Gonzalez-Valdivieso J; Min IM; de Stanchina E; Britz M; von Hofe E; Jin MM
Nat Commun; 2023 Apr; 14(1):2068. PubMed ID: 37045815
[TBL] [Abstract][Full Text] [Related]
47. PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.
Jie Y; Liu G; Feng L; Li Y; E M; Wu L; Li Y; Rong G; Li Y; Wei H; Gu A
Front Immunol; 2021; 12():665970. PubMed ID: 34475869
[TBL] [Abstract][Full Text] [Related]
48. Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer.
Kobold S; Steffen J; Chaloupka M; Grassmann S; Henkel J; Castoldi R; Zeng Y; Chmielewski M; Schmollinger JC; Schnurr M; Rothenfußer S; Schendel DJ; Abken H; Sustmann C; Niederfellner G; Klein C; Bourquin C; Endres S
J Natl Cancer Inst; 2015 Jan; 107(1):364. PubMed ID: 25424197
[TBL] [Abstract][Full Text] [Related]
49. Co-infusion of CAR T cells with aAPCs expressing chemokines and costimulatory ligands enhances the anti-tumor efficacy in mice.
Li J; Zhou W; Li D; Huang Y; Yang X; Jiang L; Hu X; Yang J; Fu M; Zhang M; Wang F; Li J; Zhang Y; Yang Y; Yan F; Gao H; Wang W
Cancer Lett; 2023 Aug; 568():216287. PubMed ID: 37392990
[TBL] [Abstract][Full Text] [Related]
50. A photosensitizer delivered by bispecific antibody redirected T lymphocytes enhances cytotoxicity against EpCAM-expressing carcinoma cells upon light irradiation.
Blaudszun AR; Moldenhauer G; Schneider M; Philippi A
J Control Release; 2015 Jan; 197():58-68. PubMed ID: 25449805
[TBL] [Abstract][Full Text] [Related]
51. CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.
Oberst MD; Fuhrmann S; Mulgrew K; Amann M; Cheng L; Lutterbuese P; Richman L; Coats S; Baeuerle PA; Hammond SA
MAbs; 2014; 6(6):1571-84. PubMed ID: 25484061
[TBL] [Abstract][Full Text] [Related]
52. Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients.
Nagorsen D; Scheibenbogen C; Schaller G; Leigh B; Schmittel A; Letsch A; Thiel E; Keilholz U
Int J Cancer; 2003 Jun; 105(2):221-5. PubMed ID: 12673683
[TBL] [Abstract][Full Text] [Related]
53. Unraveling the multifaceted role of EpCAM in colorectal cancer: an integrated review of its function and interplay with non-coding RNAs.
Jiang X; Wang S; Liang Q; Liu Y; Liu L
Med Oncol; 2023 Dec; 41(1):35. PubMed ID: 38151631
[TBL] [Abstract][Full Text] [Related]
54. Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor.
Beecham EJ; Ortiz-Pujols S; Junghans RP
J Immunother; 2000; 23(3):332-43. PubMed ID: 10838662
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion.
Sun W; Li J; Jiang HG; Ge LP; Wang Y
QJM; 2014 Dec; 107(12):1001-7. PubMed ID: 24939190
[TBL] [Abstract][Full Text] [Related]
56. Logic-gated approaches to extend the utility of chimeric antigen receptor T-cell technology.
Ebert LM; Yu W; Gargett T; Brown MP
Biochem Soc Trans; 2018 Apr; 46(2):391-401. PubMed ID: 29540509
[TBL] [Abstract][Full Text] [Related]
57. Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo.
English DP; Bellone S; Schwab CL; Roque DM; Lopez S; Bortolomai I; Cocco E; Bonazzoli E; Chatterjee S; Ratner E; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Santin AD
Cancer; 2015 Feb; 121(3):403-12. PubMed ID: 25251053
[TBL] [Abstract][Full Text] [Related]
58. Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen.
Conaghan P; Ashraf S; Tytherleigh M; Wilding J; Tchilian E; Bicknell D; Mortensen NJ; Bodmer W
Br J Cancer; 2008 Apr; 98(7):1217-25. PubMed ID: 18349843
[TBL] [Abstract][Full Text] [Related]
59. T cells redirected by a CD3ζ chimeric antigen receptor can establish self-antigen-specific tumour protection in the long term.
Chmielewski M; Rappl G; Hombach AA; Abken H
Gene Ther; 2013 Feb; 20(2):177-86. PubMed ID: 22378346
[TBL] [Abstract][Full Text] [Related]
60. Identification of potential HLA-A *0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA).
Ras E; van der Burg SH; Zegveld ST; Brandt RM; Kuppen PJ; Offringa R; Warnarr SO; van de Velde CJ; Melief CJ
Hum Immunol; 1997 Mar; 53(1):81-9. PubMed ID: 9127151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
